Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome

Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome

Introduction: The neonate exposed to opioids in utero faces a constellation of withdrawal symptoms postpartum commonly called neonatal opioid withdrawal syndrome (NOWS). The incidence of NOWS has increased in recent years due to the opioid epidemic. MicroRNAs (miRNAs) are small non-coding RNA molecu...

Full description

Bibliographic Details
Main Authors:	Uppala Radhakrishna, Swapan K. Nath, Lavanya V. Uppala, Avinash Veerappa, Ariadna Forray, Srinivas B. Muvvala, Raghu P. Metpally, Richard C. Crist, Wade H. Berrettini, Lori M. Mausi, Sangeetha Vishweswaraiah, Ray O. Bahado-Singh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Genetics
Subjects:	MicroRNAs opioid use disorder (OUD) neonatal opioid withdrawal syndrome (NOWS) methylation biomarkers
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2023.1215472/full

Similar Items

Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizons
by: Uppala Radhakrishna, et al.
Published: (2024-01-01)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
by: Niraj R. Chavan, et al.
Published: (2017-10-01)

Editorial: Opioids and opioid-use disorders
by: Giordano de Guglielmo, et al.
Published: (2023-06-01)

“It’s a proactive intervention instead of a reactive one”: measuring facilitators and barriers regarding readiness to implement a treatment program for infants with neonatal opioid withdrawal syndrome
by: Leah Holcomb, et al.
Published: (2023-07-01)

Prenatal opioid exposure significantly impacts placental protein kinase C (PKC) and drug transporters, leading to drug resistance and neonatal opioid withdrawal syndrome
by: Uppala Radhakrishna, et al.
Published: (2024-08-01)

Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse
by: Vanessa Troiani, et al.
Published: (2021-10-01)

Endogenous opioid systems alterations in pain and opioid use disorder
by: Jessica A. Higginbotham, et al.
Published: (2022-10-01)

Patient Perceptions and Potential Utility of Pharmacogenetic Testing in Chronic Pain Management and Opioid Use Disorder in the Camden Opioid Research Initiative
by: Dara Kusic, et al.
Published: (2022-09-01)

Linking the gut microbiome to microglial activation in opioid use disorder
by: Danielle Antoine, et al.
Published: (2022-12-01)

Prescription opioid use in Israel – the tide has risen, but it’s not a tidal wave
by: Yehuda Neumark, et al.
Published: (2024-10-01)

The impact of the opioid crisis on U.S. state prison systems
by: Christy K. Scott, et al.
Published: (2021-07-01)

Emergency department management of opioid use disorder in pediatric patients
by: Evan S. Schwarz, et al.
Published: (2024-10-01)

Importance of pharmacist-patient relationship in people living with HIV and concomitant opioid use disorder
by: Alina Cernasev, et al.
Published: (2021-09-01)

An ethnographic study of opioid use disorder in rural Maine: The problem of pain
by: Weronika Grabowska, et al.
Published: (2021-02-01)

Barriers, perceived benefits and preferences to exercise in adults with an opioid use disorder in the U.S
by: Nora L. Nock, et al.
Published: (2023-12-01)

A Glitch in the Matrix: The Role of Extracellular Matrix Remodeling in Opioid Use Disorder
by: Madelyn H. Ray, et al.
Published: (2022-06-01)

Machine learning and deep learning frameworks for the automated analysis of pain and opioid withdrawal behaviors
by: Jacob R. Bumgarner, et al.
Published: (2022-09-01)

Neonatal opioid withdrawal syndrome and implications for pain assessment in the newborn: a scoping review
by: Sriya Roychaudhuri, et al.
Published: (2024-03-01)

Opioid system and related ligands: from the past to future perspectives
by: Laura Rullo, et al.
Published: (2024-10-01)

Prevalence of alcohol consumption among clients of opioid agonist treatment (OAT) centers in Golestan province, Iran
by: Alireza Noroozi, et al.
Published: (2023-05-01)

Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)
by: Adam Czynski, et al.
Published: (2023-07-01)

The risk of opioid use disorder among women undergoing obstetric-related procedures: Results from the Cerner Real-World Database
by: Fares Qeadan, et al.
Published: (2024-03-01)

The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting
by: Lindsay Mackay, et al.
Published: (2021-04-01)

Novel digital approaches to the assessment of problematic opioid use
by: Philip J. Freda, et al.
Published: (2022-07-01)

Recovery from opioid use on a neuropsychoanalytic service
by: Ross Meadon, et al.
Published: (2024-06-01)

Association of Receipt of Opioid Prescription for Acute Post-Delivery Pain Management with Buprenorphine Discontinuation among Postpartum People with Opioid Use Disorder
by: Taylor N. Hallet, et al.
Published: (2024-04-01)

Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome
by: Dorothea D. Jenkins, et al.
Published: (2021-03-01)

Stopping or Decreasing Opioid Therapy in Patients on Chronic Opioid Therapy
by: Joseph V. Pergolizzi, et al.
Published: (2019-08-01)

Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S.
by: Christy K. Scott, et al.
Published: (2022-12-01)

Effect of Prenatal Opioid Exposure on the Human Placental Methylome
by: Kristyn N. Borrelli, et al.
Published: (2022-05-01)

Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report
by: Gavin B. Bart, et al.
Published: (2020-01-01)

Opioid Dosage Levels, Concurrent Risk Factors and Self-Perceptions among Chronic Pain, Opioid-Managed Individuals at Elevated Risk for Opioid Overdose
by: Matthew S. Ellis, et al.
Published: (2021-12-01)

Characterization of inpatient care for patients admitted to a psychiatric hospital with a home opioid prescription
by: Kei Takamura, PharmD, BCPS, BCPP, et al.
Published: (2023-03-01)

Integrating Cognitive Dysfunction Accommodation Strategies Into Behavioral Interventions for Persons on Medication for Opioid Use Disorder
by: Colleen B. Mistler, et al.
Published: (2022-02-01)

Addressing opioid tolerance and opioid‐induced hypersensitivity: Recent developments and future therapeutic strategies
by: Faris Khan, et al.
Published: (2021-05-01)

Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain
by: Elena Ruggiero, et al.
Published: (2023-09-01)

Opioids and Chronic Pain: An Analytic Review of the Clinical Evidence
by: Stephen E. Nadeau, et al.
Published: (2021-08-01)

Fetal and Infant Effects of Maternal Opioid Use during Pregnancy: A Literature Review including Clinical, Toxicological, Pharmacogenomic, and Epigenetic Aspects for Forensic Evaluation
by: Elena Giovannini, et al.
Published: (2024-02-01)

A scoping review of community-based post-opioid overdose intervention programs: implications of program structure and outcomes
by: Amelia Bailey, et al.
Published: (2023-01-01)

Opioid Poisoning and Opioid Use Disorder in Older Trauma Patients
by: Daoust R, et al.
Published: (2020-05-01)